Cargando…
Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study
Gonorrhea is a major global public health problem with emergence of multiple drug-resistant strains with no effective vaccine. This retrospective cohort study aimed to estimate the effectiveness of the New Zealand meningococcal B vaccine against gonorrhea-associated hospitalization. The cohort consi...
Autores principales: | Paynter, Janine, Goodyear-Smith, Felicity, Morgan, Jane, Saxton, Peter, Black, Steven, Petousis-Harris, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466174/ https://www.ncbi.nlm.nih.gov/pubmed/30621260 http://dx.doi.org/10.3390/vaccines7010005 |
Ejemplares similares
-
Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”
por: Paynter, Janine, et al.
Publicado: (2019) -
Comment on “Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”
por: Kenyon, Chris
Publicado: (2019) -
Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents
por: Petousis-Harris, Helen, et al.
Publicado: (2015) -
Expression of outer membrane protein II by gonococci in experimental gonorrhea
Publicado: (1988) -
Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines
por: Petousis-Harris, Helen, et al.
Publicado: (2019)